Cover Image
市場調查報告書

亞太地區的體外受精(IVF)服務市場:各周期類型(fresh周期、凍結受精卵的體外受精周期、卵子提供的體外受精周期)、各終端用戶 - 機會分析與產業預測

Asia-Pacific In-Vitro Fertilization Services Market by Cycle Type and End Users - Opportunity Analysis and Industry Forecast, 2014-2022

出版商 Allied Market Research 商品編碼 421143
出版日期 內容資訊 英文 235 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
亞太地區的體外受精(IVF)服務市場:各周期類型(fresh周期、凍結受精卵的體外受精周期、卵子提供的體外受精周期)、各終端用戶 - 機會分析與產業預測 Asia-Pacific In-Vitro Fertilization Services Market by Cycle Type and End Users - Opportunity Analysis and Industry Forecast, 2014-2022
出版日期: 2016年12月01日 內容資訊: 英文 235 Pages
簡介

本報告提供亞太地區的體外受精(IVF)服務市場相關調查,市場趨勢與課題,各國的各周期類型,各終端用戶趨勢,主要供應商簡介等彙整資料。

第1章 簡介

第2章 摘要整理

第3章 市場分析

  • 市場定義和範圍
  • 概要
  • 促進要素
  • 阻礙要素
  • 各國市場
  • 各周期類型市場
  • 各終端用戶市場
  • 企業簡介
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA

第4章 印度的胚移植市場

  • 概要
  • 各終端用戶市場
    • 不孕診所
    • 醫院
    • 外科中心
    • 臨床研究機關
  • 各周期類型市場
  • 促進要素
  • 阻礙要素
  • 法律規章的問題,法規,當局
  • 保險償付方案
  • 企業/醫院/診所簡介

第5章 中國的胚移植市場

第6章 日本的胚移植市場

第7章 澳洲的胚移植市場

第8章 紐西蘭的胚移植市場

第9章 韓國的胚移植市場

第10章 泰國的胚移植市場

第11章 新加坡的胚移植市場

第12章 馬來西亞的胚移植市場

第13章 印尼的胚移植市場

第14章 菲律賓的胚移植市場

第15章 越南的胚移植市場

第16章 其他亞太地區各國的胚移植市場

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: LI 16853

Title:
Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022.

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The Asia Pacific IVF services market, valued at $3.0 billion in 2015, is estimated to reach $7.1 billion by 2022. Delayed pregnancy in women is one of the major driving factors of the embryo transfer market, as the chances of conceiving lowers with age. Success rate of getting pregnant with embryo transfer technique reduces with increase in age. Other driving factors of the embryo transfer market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, around 15% of the couples faces infertility issues in which males contribute to 20-30% of the overall cases.

The major limiting factors of this market are the cost involved and lower success rates in the treatment. Patients may not conceive in the first cycle of embryo transfer procedure. Patients have to undergo many cycles to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $3,000- $8,000. This acts as a major limitation, in adoption of the technique, for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria, India, Indonesia among others. Awareness can be created through medical tourism and availability of low cost embryo transfer treatments. The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Fisher Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ovascience Inc.

KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides an in-depth analysis of the Asia-Pacific IVF market across twelve major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
  • The report includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market.
  • This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region.
  • The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022.
  • Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.

KEY MARKET SEGMENTS:

By End Users (Value and Volume)

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Cycle Type, (Value and Volume)

  • Fresh Cycle (Non-Donor)
  • Thawed IVF Cycle (Non-Donor)
  • Donor Egg IVF Cycles

By Cycle Type Country Level Analysis (Value and Volume)

  • India
  • China
  • Japan
  • Australia
  • New Zealand
  • Korea
  • Thailand
  • Singapore
  • Malaysia
  • Indonesia
  • Philippines
  • Vietnam
  • Rest of Asia-Pacific

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1 Report description
  • 1.2 Key benefits
  • 1.3 Coverage and limitations
  • 1.4 Research methodology
    • 1.4.1 Secondary research
    • 1.4.2 Primary research
    • 1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 ASIA-PACIFIC IVF MARKET ANALYSIS

  • 3.1 Market definition and scope
  • 3.2 Overview
  • 3.3 Drivers
    • 3.3.1 Delay in family planning reduces chances of conception
    • 3.3.2 Decline in birth rate
    • 3.3.3 Emotional problems
  • 3.4 Restraints
  • 3.5 Asia-Pacific embryo transfer market, by Country
  • 3.6 Asia-Pacific embryo transfer market by Cycle Types
  • 3.7 Asia-Pacific embryo transfer market by End Users
  • 3.8 Company Profile
    • 3.8.1 Thermo Fisher Scientific, Inc.
    • 3.8.2 Merck KGaA

CHAPTER 4 INDIA EMBRYO TRANSFER MARKET

  • 4.1 Overview
  • 4.2 India Embryo Transfer Market by End Users
    • 4.2.1 Fertility clinics
    • 4.2.2 Hospitals
    • 4.2.3 Surgical centers
    • 4.2.4 Clinical research institutes
  • 4.3 India IVF Market by Cycle Type
    • 4.3.1 Fresh IVF cycles (non-donor)
    • 4.3.2 Thawed IVF cycles (non-donor)
    • 4.3.3 Donor egg IVF cycles
  • 4.4 Drivers
  • 4.5 Restraints
  • 4.6 Regulatory issues, legislations, and authorities
  • 4.7 Insurance reimbursement scenario
  • 4.8 Company/Hospitals/Clinics Profile
    • 4.8.1 Sun Pharmaceutical Industries Ltd.
    • 4.8.2 Trivector Origio Scientific Pvt. Ltd
    • 4.8.3 Lab IVF Asia Pte. Ltd.
    • 4.8.4 LG Life Sciences.
    • 4.8.5 Cadila Healthcare Ltd. (Zydus Cadila group)
    • 4.8.6 Bourn Hall Clinic
    • 4.8.7 Morpheus IVF Fertility Center
    • 4.8.8 Southend Fertility and IVF Centre
    • 4.8.9 Nova IVI Fertility
    • 4.8.10 Bloom Fertility Center
    • 4.8.11 Manipal Ankur
    • 4.8.12 Cloudnine

CHAPTER 5 CHINA EMBRYO TRANSFER MARKET

  • 5.1 Overview
  • 5.2 China Embryo Transfer Market by End Users
    • 5.2.1 Fertility clinics
    • 5.2.2 Hospitals
    • 5.2.3 Surgical centers
    • 5.2.4 Clinical research institutes
  • 5.3 China IVF Market by Cycle Type
    • 5.3.1 Fresh IVF cycles (non-donor)
    • 5.3.2 Thawed IVF cycles (non-donor)
    • 5.3.3 Donor egg IVF cycles
  • 5.4 Drivers
    • 5.4.1 Increased rate of infertility
    • 5.4.2 Change in lifestyle
  • 5.5 Restraints
    • 5.5.1 Cost of living
  • 5.6 Regulatory issues, legislations, and authorities
  • 5.7 Insurance reimbursement scenario
  • 5.8 Company/Hospitals/Clinics Profile
    • 5.8.1 Cook Medical, Inc.
    • 5.8.2 Vitrolife AB
    • 5.8.3 Centre for Reproductive Medicine
    • 5.8.4 Reproductive & Genetic Hospital Citic-Xiangya
    • 5.8.5 Shenyang International Hospital
    • 5.8.6 Shandong Provincial Hospital

CHAPTER 6 JAPAN EMBRYO TRANSFER MARKET

  • 6.1 Overview
  • 6.2 Japan Embryo Transfer Market by End Users
    • 6.2.1 Fertility clinics
    • 6.2.2 Hospitals
    • 6.2.3 Surgical centers
    • 6.2.4 Clinical research institutes
  • 6.3 Japan IVF Market by Cycle Type
    • 6.3.1 Fresh IVF cycles (non-donor)
    • 6.3.2 Thawed IVF cycles (non-donor)
  • 6.4 Drivers
  • 6.5 Restraints
  • 6.6 Regulatory issues, legislations, and authorities
  • 6.7 Insurance reimbursement scenario
  • 6.8 Company/Hospitals/Clinics Profile
    • 6.8.1 Merck KGaA
    • 6.8.2 IVF Namba Clinic
    • 6.8.3 Iwaki Womens Clinic
    • 6.8.4 Sanno Hospital

CHAPTER 7 AUSTRALIA EMBRYO TRANSFER MARKET

  • 7.1 Overview
  • 7.2 Australia Embryo Transfer Market by End Users
    • 7.2.1 Fertility clinics
    • 7.2.2 Hospitals
    • 7.2.3 Surgical centers
    • 7.2.4 Clinical research institutes
  • 7.3 Australia IVF Market by Cycle Type
    • 7.3.1 Fresh IVF cycles (non-donor)
    • 7.3.2 Thawed IVF cycles (non-donor)
  • 7.4 Drivers
  • 7.5 Restraints
    • 7.5.1 Emotional and physical stress
    • 7.5.2 No guarantee
    • 7.5.3 Surplus embryos
  • 7.6 Regulatory issues, legislations, and authorities
    • 7.6.1 Common Law
    • 7.6.2 Legislative responses to IVF
    • 7.6.3 Non-legislative regulation for the practice of IVF
  • 7.7 Insurance reimbursement scenario
  • 7.8 Company/Hospitals/Clinics Profile
    • 7.8.1 Genea Biomedx
    • 7.8.2 Thermo Fisher Scientific, Inc.
    • 7.8.3 Virtus Health
    • 7.8.4 Monash IVF
    • 7.8.5 City Fertility
    • 7.8.6 Flinders Fertility

CHAPTER 8 NEW ZEALAND EMBRYO TRANSFER MARKET

  • 8.1 Overview
  • 8.2 New Zealand Embryo Transfer Market by End Users
    • 8.2.1 Fertility clinics
    • 8.2.2 Hospitals
    • 8.2.3 Surgical centers
    • 8.2.4 Clinical research institutes
  • 8.3 New Zealand IVF Market by Cycle Type
    • 8.3.1 Fresh IVF cycles (non-donor)
    • 8.3.2 Thawed IVF cycles (non-donor)
    • 8.3.3 Donor egg IVF cycles
  • 8.4 Drivers
  • 8.5 Restraints
  • 8.6 Regulatory issues, legislations, and authorities
  • 8.7 Insurance reimbursement scenario
  • 8.8 Hospitals/Clinics Profile
    • 8.8.1 Fertility Associates
    • 8.8.2 Fertility Plus
    • 8.8.3 Reporomed

CHAPTER 9 KOREA EMBRYO TRANSFER MARKET

  • 9.1 Overview
  • 9.2 Korea Embryo Transfer Market by End Users
    • 9.2.1 Fertility clinics
    • 9.2.2 Hospitals
    • 9.2.3 Surgical centers
    • 9.2.4 Clinical research institutes
  • 9.3 Korea IVF Market by Cycle Type
    • 9.3.1 Fresh IVF cycles (non-donor)
    • 9.3.2 Thawed IVF cycles (non-donor)
    • 9.3.3 Donor egg IVF cycles
  • 9.4 Drivers
  • 9.5 Restraints
  • 9.6 Regulatory issues, legislations, and authorities
  • 9.7 Insurance reimbursement scenario
  • 9.8 Hospitals/Clinics Profile
    • 9.8.1 Cha General Hospital
    • 9.8.2 Maria Fertility Hospital

CHAPTER 10 THAILAND EMBRYO TRANSFER MARKET

  • 10.1 Overview
  • 10.2 Thailand Embryo Transfer Market by End Users
    • 10.2.1 Fertility clinics
    • 10.2.2 Hospitals
    • 10.2.3 Surgical centers
    • 10.2.4 Clinical research institutes
  • 10.3 Thailand IVF Market by Cycle Type
    • 10.3.1 Fresh IVF cycles (non-donor)
    • 10.3.2 Thawed IVF cycles (non-donor)
    • 10.3.3 Donor egg IVF cycles
  • 10.4 Drivers
    • 10.4.1 Government initiatives
    • 10.4.2 Surrogacy is economical as compared to developed countries
    • 10.4.3 Boost in medical tourism
  • 10.5 Restraints
    • 10.5.1 Comparatively low success rate
    • 10.5.2 Ethical issues in allowing gender selection
  • 10.6 Regulatory issues, legislations, and authorities
  • 10.7 Insurance reimbursement scenario
  • 10.8 Hospitals/Clinics Profile
    • 10.8.1 Bangkok Fertility Center
    • 10.8.2 Siriraj Hospital
    • 10.8.3 Ramathibodi Hospital
    • 10.8.4 Perfect Woman Institute Piyavate Hospital
    • 10.8.5 Jetanin Institute for Assisted Reproduction

CHAPTER 11 SINGAPORE EMBRYO TRANSFER MARKET

  • 11.1 Overview
  • 11.2 Singapore Embryo Transfer Market by End Users
    • 11.2.1 Fertility clinics
    • 11.2.2 Hospitals
    • 11.2.3 Surgical centers
    • 11.2.4 Clinical research institutes
  • 11.3 Singapore IVF Market by Cycle Type
    • 11.3.1 Fresh IVF cycles (non-donor)
    • 11.3.2 Thawed IVF cycles (non-donor)
  • 11.4 Drivers
    • 11.4.1 Government funding and tax rebates for parents
    • 11.4.2 Rising infertility rate
    • 11.4.3 Increase in success rate
  • 11.5 Restraints
    • 11.5.1 High cost of IVF treatment and lower success rate
  • 11.6 Regulatory issues, legislations, and authorities
  • 11.7 Insurance reimbursement scenario
  • 11.8 Company/Clinics Profile
    • 11.8.1 Irvine Scientific
    • 11.8.2 ESCO Technologies Inc.
    • 11.8.3 Leica Microsystems GMBH
    • 11.8.4 NUH IVF Centre
    • 11.8.5 Mount Elizabeth Fertility Center
    • 11.8.6 Thomson Fertility Centre
    • 11.8.7 Raffles Fertility Centre

CHAPTER 12 MALAYSIAN EMBRYO TRANSFER MARKET

  • 12.1 Overview
  • 12.2 Malaysia Embryo Transfer Market by End Users
    • 12.2.1 Fertility clinics
    • 12.2.2 Hospitals
    • 12.2.3 Surgical centers
    • 12.2.4 Clinical research institutes
  • 12.3 Malaysia IVF Market by Cycle Type
    • 12.3.1 Fresh IVF cycles (non-donor)
    • 12.3.2 Thawed IVF cycles (non-donor)
    • 12.3.3 Donor egg IVF cycles
  • 12.4 Drivers
    • 12.4.1 Increase in government initiatives
    • 12.4.2 Increase in the number of foreign patients
    • 12.4.3 Decrease in rate of fertility and growing acceptability of IVF
  • 12.5 Restraints
  • 12.6 Regulatory issues, legislations, and authorities
  • 12.7 Insurance reimbursement scenario
  • 12.8 Clinics Profile
    • 12.8.1 Subang Fertility Center
    • 12.8.2 Concept Fertility Centre
    • 12.8.3 TMC Fertility Center

CHAPTER 13 INDONESIAN EMBRYO TRANSFER MARKET

  • 13.1 Overview
  • 13.2 Indonesia Embryo Transfer Market by End Users
    • 13.2.1 Fertility clinics
    • 13.2.2 Hospitals
    • 13.2.3 Surgical centers
    • 13.2.4 Clinical research institutes
  • 13.3 Indonesia IVF Market by Cycle Type
    • 13.3.1 Fresh IVF cycles (non-donor)
    • 13.3.2 Thawed IVF cycles (non-donor)
    • 13.3.3 Donor egg IVF cycles
  • 13.4 Drivers
    • 13.4.1 Increase in disposable income
    • 13.4.2 Advances in embryo transfer technology
    • 13.4.3 Decline in fertility rate
  • 13.5 Restraints
    • 13.5.1 Physical and emotional impact due to low success rate
  • 13.6 Regulatory issues, legislations, and authorities
  • 13.7 Insurance reimbursement scenario
  • 13.8 Clinics Profile
    • 13.8.1 Morula IVF
    • 13.8.2 Yasmin IVF
    • 13.8.3 Aster Fertility Clinic
    • 13.8.4 Fertility Centre, Siloam Hospitals Surabana

CHAPTER 14 PHILIPPINES EMBRYO TRANSFER MARKET

  • 14.1 Overview
  • 14.2 Philippines Embryo Transfer Market by End Users
    • 14.2.1 Fertility clinics
    • 14.2.2 Hospitals
    • 14.2.3 Surgical centers
    • 14.2.4 Clinical research institutes
  • 14.3 Philippines IVF market by cycle type
    • 14.3.1 Fresh IVF cycles (non-donor)
    • 14.3.2 Thawed IVF cycles (non-donor)
    • 14.3.3 Donor egg IVF cycles
  • 14.4 Drivers
    • 14.4.1 Improve the replacement population
    • 14.4.2 Advancement in technology
  • 14.5 Restraints
  • 14.6 Regulatory issues, legislations, and authorities
  • 14.7 Insurance reimbursement scenario
  • 14.8 Clinic Profile
    • 14.8.1 Victory Art Lab
    • 14.8.2 CRM-MIA-Philippines

CHAPTER 15 VIETNAM EMBRYO TRANSFER MARKET

  • 15.1 Overview
  • 15.2 Vietnam Embryo Transfer Market by End Users
    • 15.2.1 Fertility clinics
    • 15.2.2 Hospitals
    • 15.2.3 Surgical centers
    • 15.2.4 Clinical research institutes
  • 15.3 Vietnam IVF market by cycle type
    • 15.3.1 Fresh IVF cycles (non-donor)
    • 15.3.2 Thawed IVF cycles (non-donor)
    • 15.3.3 Donor egg IVF cycles
  • 15.4 Drivers
    • 15.4.1 Decline in fertility rate
    • 15.4.2 Reasonable cost and good success rate
  • 15.5 Restraints
  • 15.6 Regulatory issues, legislations, and authorities
  • 15.7 Insurance reimbursement scenario
  • 15.8 Hospital/Clinic Profile
    • 15.8.1 IVF Lab Tu Du Hospital Vietnam
    • 15.8.2 IVF Van Hanh
    • 15.8.3 Sinh Hospital
    • 15.8.4 Tu Du - Ho Chi Minh City Vietnam

CHAPTER 16 REST OF ASIA-PACIFIC EMBRYO TRANSFER MARKET

  • 16.1 Overview
  • 16.2 Rest of Asia-Pacific Embryo Transfer Market by End Users
    • 16.2.1 Fertility clinics
    • 16.2.2 Hospitals
    • 16.2.3 Surgical centers
    • 16.2.4 Clinical research institutes
  • 16.3 Rest of Asia-Pacific IVF Market by Cycle Type
    • 16.3.1 Fresh IVF cycles (non-donor)
    • 16.3.2 Thawed IVF cycles (non-donor)
    • 16.3.3 Donor egg IVF cycles
  • 16.4 Drivers
    • 16.4.1 Increase in disposable income
    • 16.4.2 Advances in IVF technology
    • 16.4.3 Decline in fertility rate
  • 16.5 Restraints
    • 16.5.1 Physical and emotional impact due to low success rate
  • 16.6 Regulatory Issues, legislations, and Authorities
  • 16.7 Insurance Reimbursement Scenario
  • 16.8 Hospitals/Clinics Profile
    • 16.8.1 Fertility Centre, Siloam Hospitals Surabana
    • 16.8.2 CRM-MIA-Philippines
    • 16.8.3 IVFAS

List of Tables

  • TABLE 1 ASIA-PACIFIC IVF CYCLES MARKET VOLUME, BY COUNTRY, 2014-2022(THOUSAND)
  • TABLE 2 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY COUNTRY, 2014-2022($MILLION)
  • TABLE 3 ASIA-PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 4 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 5 ASIA-PACIFIC EMBRYO TRANSFER MARKET VOLUME, BY END USER, 2015-2022 (THOUSAND)
  • TABLE 6 ASIA-PACIFIC EMBRYO TRANSFER MARKET REVENUE, BY END USER, 2015-2022 ($MILLION)
  • TABLE 7 THERMO FISHER SCIENTIFIC, INC., BUSINESS OVERVIEW
  • TABLE 8 COMPANY SNAPSHOT
  • TABLE 9 MERCK KGAA: BUSINESS OVERVIEW
  • TABLE 10 COMPANY SNAPSHOT
  • TABLE 11 INDIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 12 INDIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 13 INDIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 14 INDIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 15 INDIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 16 SUN PHARMACEUTICAL BUSINESS OVERVIEW
  • TABLE 17 COMPANY SNAPSHOT
  • TABLE 18 TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEW
  • TABLE 19 COMPANY SNAPSHOT
  • TABLE 20 LAB IVF ASIA BUSINESS OVERVIEW
  • TABLE 21 COMPANY SNAPSHOT
  • TABLE 22 LG LIFE SCIENCE BUSINESS OVERVIEW
  • TABLE 23 COMPANY SNAPSHOT
  • TABLE 24 CADILA HEALTH CARE BUSINESS OVERVIEW
  • TABLE 25 COMPANY SNAPSHOT
  • TABLE 26 CHINA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 27 CHINA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 28 CHINA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 29 CHINA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 30 CHINA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 31 COOK MEDICAL, INC. BUSINESS OVERVIEW
  • TABLE 32 COMPANY SNAPSHOT
  • TABLE 33 VITROLIFE AB, INC. BUSINESS OVERVIEW
  • TABLE 34 COMPANY SNAPSHOT
  • TABLE 35 JAPAN IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 36 JAPAN IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 37 JAPAN IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 38 JAPAN IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 39 JAPAN IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 40 EMD SERONO INC BUSINESS OVERVIEW
  • TABLE 41 COMPANY SNAPSHOT
  • TABLE 42 AUSTRALIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 43 OUTCOMES OF CYCLES OF IVF BY WOMENS AGE GROUP, 2011
  • TABLE 44 AUSTRALIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 45 AUSTRALIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 46 AUSTRALIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 47 AUSTRALIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 48 GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
  • TABLE 49 COMPANY SNAPSHOT
  • TABLE 50 THERMO FISHER SCIENTIFIC INC BUSINESS OVERVIEW
  • TABLE 51 COMPANY SNAPSHOT
  • TABLE 52 NEW ZEALAND IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 53 NEW ZEALAND IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 54 NEW ZEALAND IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 55 NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 56 NEW ZEALAND IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 57 KOREA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 58 KOREA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 59 KOREA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 60 KOREA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 61 KOREA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 62 THAILAND IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 63 THAILAND IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 64 THAILAND IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 65 THAILAND IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 66 THAILAND IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 67 SINGAPORE IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 68 SINGAPORE IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 69 SINGAPORE IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 70 SINGAPORE IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 71 SINGAPORE IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 72 IRVINE SCIENTIFIC BUSINESS OVERVIEW
  • TABLE 73 COMPANY SNAPSHOT
  • TABLE 74 ESCO TECHNOLOGIES BUSINESS OVERVIEW
  • TABLE 75 COMPANY SNAPSHOT
  • TABLE 76 LEICA MICROSYSTEMS GMBH BUSINESS OVERVIEW
  • TABLE 77 COMPANY SNAPSHOT
  • TABLE 78 MALAYSIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 79 MALAYSIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 80 MALAYSIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 81 MALAYSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 82 MALAYSIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 83 INDONESIA IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 84 INDONESIA IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 85 INDONESIA IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 86 INDONESIA IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 87 INDONESIA IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 88 PHILIPPINES IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 89 PHILIPPINES IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 90 PHILIPPINES IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 91 PHILIPPINES IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 92 PHILIPPINES IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 93 VIETNAM IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 94 VIETNAM IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 95 VIETNAM IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 96 VIETNAM IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 97 VIETNAM IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 98 REST OF ASIA-PACIFIC IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
  • TABLE 99 REST OF ASIA-PACIFIC IVF MARKET, BY END USERS, 2014-2022 ($MILLION)
  • TABLE 100 REST OF ASIA-PACIFIC IVF MARKET, BY END USERS, 2014-2022 (THOUSAND)
  • TABLE 101 REST OF ASIA-PACIFIC IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 102 REST OF ASIA-PACIFIC IVF MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
  • TABLE 103 EMBRYO TRANSFER COST PER CYCLE BY COUNTRY (2014)

List of Figures

  • FIG. 1 PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY FACTORS (SINGAPORE, THAILAND, INDONESIA, AND CHINA)
  • FIG. 2 INDIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
  • FIG. 3 INDIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 4 INDIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 5 INDIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 6 INDIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 7 INDIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 8 INDIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 9 INDIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 10 CHINA FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
  • FIG. 11 CHINA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 12 CHINA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 13 CHINA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 14 CHINA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 15 CHINA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 16 CHINA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 17 CHINA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 18 JAPAN: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
  • FIG. 19 JAPAN IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 20 JAPAN IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 21 JAPAN IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 22 JAPAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 23 JAPAN IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 24 JAPAN IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 25 AUSTRALIA TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
  • FIG. 26 IVF SUCCESS RATE FOR AUSTRALIA
  • FIG. 27 AUSTRALIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 28 AUSTRALIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 29 AUSTRALIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 30 AUSTRALIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 31 AUSTRALIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 32 AUSTRALIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 33 NEW ZEALAND TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN) (2010-2014)
  • FIG. 34 NEW ZEALAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 35 NEW ZEALAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 36 NEW ZEALAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 37 NEW ZEALAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 38 NEW ZEALAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 39 NEW ZEALAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 40 NEW ZEALAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 41 SOUTH KOREA TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) (2010-2014)
  • FIG. 42 KOREA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 43 KOREA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 44 KOREA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 45 KOREA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 46 KOREA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 47 KOREA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 48 KOREA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 49 THAILAND FERTILITY RATE CHILD BORN/WOMEN (2014-2020)
  • FIG. 50 THAILAND IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 51 THAILAND IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 52 THAILAND IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 53 THAILAND IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 54 THAILAND IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 55 THAILAND IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 56 THAILAND IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 57 SINGAPORE: FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
  • FIG. 58 SINGAPORE IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 59 SINGAPORE IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 60 SINGAPORE IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 61 SINGAPORE IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 62 SINGAPORE IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 63 SINGAPORE IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 64 MALAYSIA: FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
  • FIG. 65 MALAYSIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 66 MALAYSIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 67 MALAYSIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 68 MALAYSIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 69 MALAYSIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 70 MALAYSIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 71 MALAYSIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 72 INDONESIAN FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
  • FIG. 73 INDONESIA IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 74 INDONESIA IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 75 INDONESIA IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 76 INDONESIA IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 77 INDONESIA IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 78 INDONESIA IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 79 INDONESIA IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 80 PHILIPPINES FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
  • FIG. 81 PHILIPPINES IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 82 PHILIPPINES IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 83 PHILIPPINES IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 84 PHILIPPINES IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 85 PHILIPPINES IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 86 PHILIPPINES IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 87 PHILIPPINES IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 88 VIETNAM FERTILITY RATE CHILD BORN/WOMEN (2010-2014)
  • FIG. 89 VIETNAM IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 90 VIETNAM IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 91 VIETNAM IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 92 VIETNAM IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 93 VIETNAM IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 94 VIETNAM IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 95 VIETNAM IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 96 REST OF ASIA-PACIFIC IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 97 REST OF ASIA-PACIFIC IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 98 REST OF ASIA-PACIFIC IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 99 REST OF ASIA-PACIFIC IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 100 REST OF ASIA-PACIFIC IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 101 REST OF ASIA-PACIFIC IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 102 REST OF ASIA-PACIFIC IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
Back to Top